$DAIO

DATA I/O CORP (DAIO): Results of Operations and Financial Condition

DATA I/O CORP (DAIO) filed an SEC Form 8-K — Results of Operations and Financial Condition. EX-99.0 2 daio_ex990.htm PRESS RELEASE daio_ex990.htm Exhibit 99.0 Data I/O Reports Second Quarter 2026 Results Second Quarter Revenue Tops Guidance with 59% Jump in Sequential Growth from First Quarter Transitional Acquisition on Track with Exclusivity Extended to the End of Aug

Original reporting
Published Aug 12, 2026, 8:39 PM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Aug 12, 2026, 8:42 PM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
alphai market briefEarnings
Primary signal
$DAIO
Bullish
medium confidence
Mentioned
$DAIO
Relevance
7/10
alphai data visualization · based on SEC EDGAR 8-K
Decision brief

The 30-second read

$DAIOBullishMed
01

Why it matters

Traders can update models for near-term profitability trajectory based on the reported gross margin jump, operating expense optimization, and cash increase, while also monitoring acquisition completion timing into late August.

02

Market read

Fresh Q2 financials show a clear inflection in revenue and gross margin, plus balance-sheet strengthening and acquisition momentum, which can drive repricing versus prior expectations.

03

What to watch

Backlog and deferred revenue both fell sequentially, and the acquisition timeline is still pending (exclusivity extended only through end of August), leaving execution and integration risk.

Relevance 7/10Novelty 7/10Timing: after-hours filing today, Q2 results and acquisition exclusivity update

Background

The 8-K Item 2.02 includes a press release with Q2 2026 results, operating cost actions, cash position, and updates on two planned acquisitions (one exclusivity extension and another intent to acquire IAR embedded security IP).

Company-level read

Ticker impact

$DAIOBullishMedium confidence
Context

Data I/O reported Q2 2026 net sales of $5.2M, up 59% sequentially, plus gross margin expansion to 57% and a $9M direct investment in May.

Expected impact

Bias upward for the next session and into earnings follow-through, but with volatility risk if investors focus on backlog decline and execution risk on acquisitions.

Evidence & confidence

The article provides multiple fresh, decision-relevant datapoints (revenue, bookings, gross margin, cash, and acquisition exclusivity timing). However, it also shows backlog down and does not include full guidance or deal economics, limiting conviction on magnitude/duration.

Market effects

Signals improving demand and mix shift in embedded programming and security provisioning, potentially supportive for peers serving microcontrollers and security IC ecosystems.

Limited direct regional read-through; primarily company-specific execution and balance-sheet news.

EU Cyber Resilience Act mention may support broader embedded security spend narrative, but this filing is not a sector-wide regulatory action.

Counterpoint

Sequential revenue and margin gains may be partly mix-driven and could reverse if bookings do not convert, especially with backlog declining to $2.1M.

Key entities

  • Data I/O Corporation

    NASDAQ-listed provider of data programming and security provisioning solutions; reported Q2 2026 results and acquisition progress in an 8-K.

  • IAR embedded software security IP

    Embedded software security IP and related assets Data I/O intends to acquire, building an end-to-end security platform.

Related articles

$DAIOMed

DATA I/O CORP (DAIO): Results of Operations and Financial Condition

DATA I/O CORP (DAIO) filed an SEC Form 8-K — Results of Operations and Financial Condition. daio_8k.htm 0000351998 false 0000351998 2026-07-30 2026-07-30 iso4217:USD xbrli:shares iso4217:USD xbrli:shares UNITED STATES SECURITIES AND EXCHANGE COMMISSION FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of

$DAIOMed

O Proposes to Acquire Embedded Software Security Assets from IAR – IT Business Net

Data I/O Corp (NASDAQ: DAIO) said it entered a non-binding LOI to acquire embedded software security IP and related assets from I.A.R. Systems AB. Terms and timing were not disclosed. Data I/O plans to bring in-house IAR’s Embedded Trust and Secure Deploy platforms and provisioning infrastructure, while the February 2026 collaboration continues. The deal aims to support EU Cyber Resilience Act compliance.

$DAIOMed

Data I/O To Buy Embedded Software Security IP & Related Assets From IAR Systems For Undisclosed Sum

Data I/O Corp (DAIO) said it entered a non-binding LOI to buy IAR Systems AB’s embedded software security IP and related assets for undisclosed terms. The deal follows a February collaboration on unifying security provisioning from embedded design through manufacturing. DAIO expects to integrate IAR’s security stack into its roadmap and device support. DAIO shares were up 2.06% at $3.7150.

$DAIOMed

Data I/O Proposes to Acquire Embedded Software Security Assets from IAR

Data I/O (NASDAQ: DAIO) said it entered a non-binding LOI to acquire embedded software security IP and related assets from I.A.R. Systems AB (IAR). Terms and timing were not disclosed. Data I/O plans to bring in-house IAR’s Embedded Trust and Secure Deploy platforms and provisioning infrastructure, while the February 2026 collaboration continues.

$DAIOMedAI 8/10

Data I/O Announces Closing of $9 Million Investment

Data I/O Corp. (NASDAQ: DAIO) said it has closed a previously announced private securities purchase agreement raising $9 million gross before fees. The deal issued 869,840 shares, convertible debentures totaling about $6.8 million at 4% interest, and warrants for up to 1.08 million shares (exercise price $3.00, 5-year term). Proceeds will fund working capital and general purposes, including potential acquisitions, with stockholder approval required for automatic conversion into Series B preferre

$ABCLMedAI 8/10

AbCellera Reports Q2 2026 Results, Advances ABCL635 And T-Cell Engager Pipeline

AbCellera (ABCL) reported Q2 2026 revenue of $4.1M, down from $17.1M YoY, with a net loss of $55.4M. The company advanced its pipeline, including ABCL635, which met primary endpoints in a Phase 2 study, and announced collaborations with Jazz and Vertex Pharmaceuticals, receiving upfront payments totaling $112M. ABCL ended the quarter with $675M in liquidity. Shares are up 16.78% to $12.40.